Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 15 entries
Sorted by: Best Match Show Resources per page
Standards of suitability for the management of chronic obstructive respiratory diseases.

Multidisciplinary respiratory medicine

Sanguinetti CM, Ambrosino N, Andò F, De Benedetto F, Donner CF, Nardini S, Polverino M, Torchio R, Vagheggini G, Visconti A.
PMID: 25584191
Multidiscip Respir Med. 2014 Dec 18;9(1):65. doi: 10.1186/2049-6958-9-65. eCollection 2014.

BACKGROUND: Chronic Obstructive Pulmonary Disease (COPD) ranks third as cause of mortality and disability-adjusted life years (DALY) worldwide and also in Italy it imposes a huge health, social and economic load. Early symptoms of COPD are often disregarded by...

Cite
Sanguinetti CM, Ambrosino N, Andò F, et al. Standards of suitability for the management of chronic obstructive respiratory diseases. Multidiscip Respir Med. 2014;9(1):65doi: 10.1186/2049-6958-9-65.
Sanguinetti, C. M., Ambrosino, N., Andò, F., De Benedetto, F., Donner, C. F., Nardini, S., Polverino, M., Torchio, R., Vagheggini, G., Visconti, A. (2014). Standards of suitability for the management of chronic obstructive respiratory diseases. Multidisciplinary respiratory medicine, 9(1), 65. https://doi.org/10.1186/2049-6958-9-65
Sanguinetti, Claudio M, et al. "Standards of suitability for the management of chronic obstructive respiratory diseases." Multidisciplinary respiratory medicine vol. 9,1 (2014): 65. doi: https://doi.org/10.1186/2049-6958-9-65
Sanguinetti CM, Ambrosino N, Andò F, De Benedetto F, Donner CF, Nardini S, Polverino M, Torchio R, Vagheggini G, Visconti A. Standards of suitability for the management of chronic obstructive respiratory diseases. Multidiscip Respir Med. 2014 Dec 18;9(1):65. doi: 10.1186/2049-6958-9-65. eCollection 2014. PMID: 25584191; PMCID: PMC4290399.
Copy Download .nbib Format: NLM
Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer.

Journal of clinical medicine

Ulivi P, Petracci E, Marisi G, Baglivo S, Chiari R, Billi M, Canale M, Pasini L, Racanicchi S, Vagheggini A, Delmonte A, Mariotti M, Ludovini V, Bonafè M, Crinò L, Grignani F.
PMID: 30678026
J Clin Med. 2019 Jan 23;8(2). doi: 10.3390/jcm8020131.

Non-small cell lung cancer (NSCLC) is the primary cause of cancer-related death worldwide, with a low 5-year survival rate even in fully resected early-stage disease. Novel biomarkers to identify patients at higher risk of relapse are needed. We studied...

Cite
Ulivi P, Petracci E, Marisi G, et al. Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer. J Clin Med. 2019;8(2)doi: 10.3390/jcm8020131.
Ulivi, P., Petracci, E., Marisi, G., Baglivo, S., Chiari, R., Billi, M., Canale, M., Pasini, L., Racanicchi, S., Vagheggini, A., Delmonte, A., Mariotti, M., Ludovini, V., Bonafè, M., Crinò, L., & Grignani, F. (2019). Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer. Journal of clinical medicine, 8(2), . https://doi.org/10.3390/jcm8020131
Ulivi, Paola, et al. "Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer." Journal of clinical medicine vol. 8,2 (2019). doi: https://doi.org/10.3390/jcm8020131
Ulivi P, Petracci E, Marisi G, Baglivo S, Chiari R, Billi M, Canale M, Pasini L, Racanicchi S, Vagheggini A, Delmonte A, Mariotti M, Ludovini V, Bonafè M, Crinò L, Grignani F. Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer. J Clin Med. 2019 Jan 23;8(2). doi: 10.3390/jcm8020131. PMID: 30678026; PMCID: PMC6407000.
Copy Download .nbib Format: NLM
Secondary Traumatic Stress and Burnout in Healthcare Workers during COVID-19 Outbreak.

International journal of environmental research and public health

Orrù G, Marzetti F, Conversano C, Vagheggini G, Miccoli M, Ciacchini R, Panait E, Gemignani A.
PMID: 33466346
Int J Environ Res Public Health. 2021 Jan 05;18(1). doi: 10.3390/ijerph18010337.

(1) Background: The present study aims to assess the level of professional burnout and secondary traumatic stress (STS), and to identify potential risk or protective factors among health care workers (HCWs) during the coronavirus disease 2019 (COVID-19) outbreak.; (2)...

Cite
Orrù G, Marzetti F, Conversano C, et al. Secondary Traumatic Stress and Burnout in Healthcare Workers during COVID-19 Outbreak. Int J Environ Res Public Health. 2021;18(1)doi: 10.3390/ijerph18010337.
Orrù, G., Marzetti, F., Conversano, C., Vagheggini, G., Miccoli, M., Ciacchini, R., Panait, E., & Gemignani, A. (2021). Secondary Traumatic Stress and Burnout in Healthcare Workers during COVID-19 Outbreak. International journal of environmental research and public health, 18(1), . https://doi.org/10.3390/ijerph18010337
Orrù, Graziella, et al. "Secondary Traumatic Stress and Burnout in Healthcare Workers during COVID-19 Outbreak." International journal of environmental research and public health vol. 18,1 (2021). doi: https://doi.org/10.3390/ijerph18010337
Orrù G, Marzetti F, Conversano C, Vagheggini G, Miccoli M, Ciacchini R, Panait E, Gemignani A. Secondary Traumatic Stress and Burnout in Healthcare Workers during COVID-19 Outbreak. Int J Environ Res Public Health. 2021 Jan 05;18(1). doi: 10.3390/ijerph18010337. PMID: 33466346; PMCID: PMC7794988.
Copy Download .nbib Format: NLM
Post-traumatic stress symptoms in long-term disease-free cancer survivors and their family caregivers.

Cancer medicine

De Padova S, Grassi L, Vagheggini A, Belvederi Murri M, Folesani F, Rossi L, Farolfi A, Bertelli T, Passardi A, Berardi A, De Giorgi U.
PMID: 34061453
Cancer Med. 2021 Jun;10(12):3974-3985. doi: 10.1002/cam4.3961. Epub 2021 Jun 01.

BACKGROUND: The experience of cancer is highly stressful and potentially traumatic. We assessed the presence of Post-Traumatic Stress Symptoms (PTSS) in long-term cancer survivors and their caregivers, while examining the association between PTSS and clinical, demographic and psychological variables...

Cite
De Padova S, Grassi L, Vagheggini A, et al. Post-traumatic stress symptoms in long-term disease-free cancer survivors and their family caregivers. Cancer Med. 2021;10(12):3974-3985doi: 10.1002/cam4.3961.
De Padova, S., Grassi, L., Vagheggini, A., Belvederi Murri, M., Folesani, F., Rossi, L., Farolfi, A., Bertelli, T., Passardi, A., Berardi, A., & De Giorgi, U. (2021). Post-traumatic stress symptoms in long-term disease-free cancer survivors and their family caregivers. Cancer medicine, 10(12), 3974-3985. https://doi.org/10.1002/cam4.3961
De Padova, Silvia, et al. "Post-traumatic stress symptoms in long-term disease-free cancer survivors and their family caregivers." Cancer medicine vol. 10,12 (2021): 3974-3985. doi: https://doi.org/10.1002/cam4.3961
De Padova S, Grassi L, Vagheggini A, Belvederi Murri M, Folesani F, Rossi L, Farolfi A, Bertelli T, Passardi A, Berardi A, De Giorgi U. Post-traumatic stress symptoms in long-term disease-free cancer survivors and their family caregivers. Cancer Med. 2021 Jun;10(12):3974-3985. doi: 10.1002/cam4.3961. Epub 2021 Jun 01. PMID: 34061453; PMCID: PMC8209622.
Copy Download .nbib Format: NLM
Sarcopenia and sarcopenic obesity in patients with muscular dystrophy.

Frontiers in aging neuroscience

Merlini L, Vagheggini A, Cocchi D.
PMID: 25339901
Front Aging Neurosci. 2014 Oct 07;6:274. doi: 10.3389/fnagi.2014.00274. eCollection 2014.

Aging sarcopenia and muscular dystrophy (MD) are two conditions characterized by lower skeletal muscle quantity, lower muscle strength, and lower physical performance. Aging is associated with a peculiar alteration in body composition called "sarcopenic obesity" characterized by a decrease...

Cite
Merlini L, Vagheggini A, Cocchi D. Sarcopenia and sarcopenic obesity in patients with muscular dystrophy. Front Aging Neurosci. 2014;6:274doi: 10.3389/fnagi.2014.00274.
Merlini, L., Vagheggini, A., & Cocchi, D. (2014). Sarcopenia and sarcopenic obesity in patients with muscular dystrophy. Frontiers in aging neuroscience, 6274. https://doi.org/10.3389/fnagi.2014.00274
Merlini, Luciano, et al. "Sarcopenia and sarcopenic obesity in patients with muscular dystrophy." Frontiers in aging neuroscience vol. 6 (2014): 274. doi: https://doi.org/10.3389/fnagi.2014.00274
Merlini L, Vagheggini A, Cocchi D. Sarcopenia and sarcopenic obesity in patients with muscular dystrophy. Front Aging Neurosci. 2014 Oct 07;6:274. doi: 10.3389/fnagi.2014.00274. eCollection 2014. PMID: 25339901; PMCID: PMC4188124.
Copy Download .nbib Format: NLM
Ventilatory response to exercise of elite soccer players.

Multidisciplinary respiratory medicine

Di Paco A, Catapano GA, Vagheggini G, Mazzoleni S, Micheli ML, Ambrosino N.
PMID: 24694313
Multidiscip Respir Med. 2014 Apr 02;9(1):20. doi: 10.1186/2049-6958-9-20.

BACKGROUND: The purpose of this study was to evaluate the role of ventilatory parameters in maximal exercise performance in elite soccer players.METHODS: From September 2009 to December 2012, 90 elite soccer players underwent evaluation of lung function test and...

Cite
Di Paco A, Catapano GA, Vagheggini G, et al. Ventilatory response to exercise of elite soccer players. Multidiscip Respir Med. 2014;9(1):20doi: 10.1186/2049-6958-9-20.
Di Paco, A., Catapano, G. A., Vagheggini, G., Mazzoleni, S., Micheli, M. L., & Ambrosino, N. (2014). Ventilatory response to exercise of elite soccer players. Multidisciplinary respiratory medicine, 9(1), 20. https://doi.org/10.1186/2049-6958-9-20
Di Paco, Adriano, et al. "Ventilatory response to exercise of elite soccer players." Multidisciplinary respiratory medicine vol. 9,1 (2014): 20. doi: https://doi.org/10.1186/2049-6958-9-20
Di Paco A, Catapano GA, Vagheggini G, Mazzoleni S, Micheli ML, Ambrosino N. Ventilatory response to exercise of elite soccer players. Multidiscip Respir Med. 2014 Apr 02;9(1):20. doi: 10.1186/2049-6958-9-20. PMID: 24694313; PMCID: PMC3977656.
Copy Download .nbib Format: NLM
Telemedicine in chronic obstructive pulmonary disease.

Breathe (Sheffield, England)

Ambrosino N, Vagheggini G, Mazzoleni S, Vitacca M.
PMID: 28210321
Breathe (Sheff). 2016 Dec;12(4):350-356. doi: 10.1183/20734735.014616.

Telemedicine is a medical application of advanced technology to disease management. This modality may provide benefits also to patients with chronic obstructive pulmonary disease (COPD). Different devices and systems are used. The legal problems associated with telemedicine are still...

Cite
Ambrosino N, Vagheggini G, Mazzoleni S, et al. Telemedicine in chronic obstructive pulmonary disease. Breathe (Sheff). 2016;12(4):350-356doi: 10.1183/20734735.014616.
Ambrosino, N., Vagheggini, G., Mazzoleni, S., & Vitacca, M. (2016). Telemedicine in chronic obstructive pulmonary disease. Breathe (Sheffield, England), 12(4), 350-356. https://doi.org/10.1183/20734735.014616
Ambrosino, Nicolino, et al. "Telemedicine in chronic obstructive pulmonary disease." Breathe (Sheffield, England) vol. 12,4 (2016): 350-356. doi: https://doi.org/10.1183/20734735.014616
Ambrosino N, Vagheggini G, Mazzoleni S, Vitacca M. Telemedicine in chronic obstructive pulmonary disease. Breathe (Sheff). 2016 Dec;12(4):350-356. doi: 10.1183/20734735.014616. PMID: 28210321; PMCID: PMC5297949.
Copy Download .nbib Format: NLM
Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?.

Cancers

Mangia A, Saponaro C, Vagheggini A, Opinto G, Centonze M, Vicenti C, Popescu O, Pastena M, Giotta F, Silvestris N.
PMID: 31540486
Cancers (Basel). 2019 Sep 18;11(9). doi: 10.3390/cancers11091393.

Tumor-infiltrating lymphocytes (TILs) are a valuable indicator of the immune microenvironment that plays the central role in new anticancer drugs. TILs have a strong prognostic role in triple negative breast cancer (TNBC). Little is known about the interaction with...

Cite
Mangia A, Saponaro C, Vagheggini A, et al. Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?. Cancers (Basel). 2019;11(9)doi: 10.3390/cancers11091393.
Mangia, A., Saponaro, C., Vagheggini, A., Opinto, G., Centonze, M., Vicenti, C., Popescu, O., Pastena, M., Giotta, F., & Silvestris, N. (2019). Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?. Cancers, 11(9), . https://doi.org/10.3390/cancers11091393
Mangia, Anita, et al. "Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?." Cancers vol. 11,9 (2019). doi: https://doi.org/10.3390/cancers11091393
Mangia A, Saponaro C, Vagheggini A, Opinto G, Centonze M, Vicenti C, Popescu O, Pastena M, Giotta F, Silvestris N. Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?. Cancers (Basel). 2019 Sep 18;11(9). doi: 10.3390/cancers11091393. PMID: 31540486; PMCID: PMC6769726.
Copy Download .nbib Format: NLM
Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience.

Diagnostics (Basel, Switzerland)

Palleschi M, Maltoni R, Ravaioli S, Vagheggini A, Mannozzi F, Fanini F, Pirini F, Tumedei MM, Barzotti E, Cecconetto L, Sarti S, Manunta S, Possanzini P, Fedeli A, Curcio A, Altini M, De Giorgi U, Rocca A, Bravaccini S.
PMID: 32784518
Diagnostics (Basel). 2020 Aug 08;10(8). doi: 10.3390/diagnostics10080573.

CDK4/6 inhibitors (CDK4/6i) are recommended in patients with estrogen receptor (ER)-positive, HER2-negative advanced breast cancer (ABC). Up to now, no prognostic biomarkers have been identified in this setting. We retrospectively analyzed the expression of progesterone receptor (PR) and Ki67,...

Cite
Palleschi M, Maltoni R, Ravaioli S, et al. Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience. Diagnostics (Basel). 2020;10(8)doi: 10.3390/diagnostics10080573.
Palleschi, M., Maltoni, R., Ravaioli, S., Vagheggini, A., Mannozzi, F., Fanini, F., Pirini, F., Tumedei, M. M., Barzotti, E., Cecconetto, L., Sarti, S., Manunta, S., Possanzini, P., Fedeli, A., Curcio, A., Altini, M., De Giorgi, U., Rocca, A., & Bravaccini, S. (2020). Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience. Diagnostics (Basel, Switzerland), 10(8), . https://doi.org/10.3390/diagnostics10080573
Palleschi, Michela, et al. "Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience." Diagnostics (Basel, Switzerland) vol. 10,8 (2020). doi: https://doi.org/10.3390/diagnostics10080573
Palleschi M, Maltoni R, Ravaioli S, Vagheggini A, Mannozzi F, Fanini F, Pirini F, Tumedei MM, Barzotti E, Cecconetto L, Sarti S, Manunta S, Possanzini P, Fedeli A, Curcio A, Altini M, De Giorgi U, Rocca A, Bravaccini S. Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience. Diagnostics (Basel). 2020 Aug 08;10(8). doi: 10.3390/diagnostics10080573. PMID: 32784518; PMCID: PMC7460222.
Copy Download .nbib Format: NLM
Unveiling mutational dynamics in non-small cell lung cancer patients by quantitative EGFR profiling in vesicular RNA.

Molecular oncology

Pasini L, Notarangelo M, Vagheggini A, Burgio MA, Crinò L, Chiadini E, Prochowski AI, Delmonte A, Ulivi P, D'Agostino VG.
PMID: 33942501
Mol Oncol. 2021 Sep;15(9):2423-2438. doi: 10.1002/1878-0261.12976. Epub 2021 May 20.

The mutational status of the epidermal growth factor receptor (EGFR) guides the stratification of non-small cell lung cancer (NSCLC) patients for treatment with tyrosine kinase inhibitors (TKIs). A liquid biopsy test on cell-free DNA is recommended as a clinical...

Cite
Pasini L, Notarangelo M, Vagheggini A, et al. Unveiling mutational dynamics in non-small cell lung cancer patients by quantitative EGFR profiling in vesicular RNA. Mol Oncol. 2021;15(9):2423-2438doi: 10.1002/1878-0261.12976.
Pasini, L., Notarangelo, M., Vagheggini, A., Burgio, M. A., Crinò, L., Chiadini, E., Prochowski, A. I., Delmonte, A., Ulivi, P., & D'Agostino, V. G. (2021). Unveiling mutational dynamics in non-small cell lung cancer patients by quantitative EGFR profiling in vesicular RNA. Molecular oncology, 15(9), 2423-2438. https://doi.org/10.1002/1878-0261.12976
Pasini, Luigi, et al. "Unveiling mutational dynamics in non-small cell lung cancer patients by quantitative EGFR profiling in vesicular RNA." Molecular oncology vol. 15,9 (2021): 2423-2438. doi: https://doi.org/10.1002/1878-0261.12976
Pasini L, Notarangelo M, Vagheggini A, Burgio MA, Crinò L, Chiadini E, Prochowski AI, Delmonte A, Ulivi P, D'Agostino VG. Unveiling mutational dynamics in non-small cell lung cancer patients by quantitative EGFR profiling in vesicular RNA. Mol Oncol. 2021 Sep;15(9):2423-2438. doi: 10.1002/1878-0261.12976. Epub 2021 May 20. PMID: 33942501; PMCID: PMC8410558.
Copy Download .nbib Format: NLM
Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis.

Frontiers in oncology

Bongiovanni A, Liverani C, Recine F, Fausti V, Mercatali L, Vagheggini A, Spadazzi C, Miserocchi G, Cocchi C, Di Menna G, De Vita A, Severi S, Nicolini S, Ibrahim T.
PMID: 32318336
Front Oncol. 2020 Apr 07;10:414. doi: 10.3389/fonc.2020.00414. eCollection 2020.

No abstract available.

Cite
Bongiovanni A, Liverani C, Recine F, et al. Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis. Front Oncol. 2020;10:414doi: 10.3389/fonc.2020.00414.
Bongiovanni, A., Liverani, C., Recine, F., Fausti, V., Mercatali, L., Vagheggini, A., Spadazzi, C., Miserocchi, G., Cocchi, C., Di Menna, G., De Vita, A., Severi, S., Nicolini, S., & Ibrahim, T. (2020). Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis. Frontiers in oncology, 10414. https://doi.org/10.3389/fonc.2020.00414
Bongiovanni, Alberto, et al. "Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis." Frontiers in oncology vol. 10 (2020): 414. doi: https://doi.org/10.3389/fonc.2020.00414
Bongiovanni A, Liverani C, Recine F, Fausti V, Mercatali L, Vagheggini A, Spadazzi C, Miserocchi G, Cocchi C, Di Menna G, De Vita A, Severi S, Nicolini S, Ibrahim T. Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis. Front Oncol. 2020 Apr 07;10:414. doi: 10.3389/fonc.2020.00414. eCollection 2020. PMID: 32318336; PMCID: PMC7154093.
Copy Download .nbib Format: NLM
A new era for Assembly 1: general pneumology.

Breathe (Sheffield, England)

Vogiatzis I, Vagheggini G, Pinnock H.
PMID: 31191730
Breathe (Sheff). 2019 Jun;15(2):147-148. doi: 10.1183/20734735.0135-2019.

No abstract available.

Cite
Vogiatzis I, Vagheggini G, Pinnock H. A new era for Assembly 1: general pneumology. Breathe (Sheff). 2019;15(2):147-148doi: 10.1183/20734735.0135-2019.
Vogiatzis, I., Vagheggini, G., & Pinnock, H. (2019). A new era for Assembly 1: general pneumology. Breathe (Sheffield, England), 15(2), 147-148. https://doi.org/10.1183/20734735.0135-2019
Vogiatzis, Ioannis, et al. "A new era for Assembly 1: general pneumology." Breathe (Sheffield, England) vol. 15,2 (2019): 147-148. doi: https://doi.org/10.1183/20734735.0135-2019
Vogiatzis I, Vagheggini G, Pinnock H. A new era for Assembly 1: general pneumology. Breathe (Sheff). 2019 Jun;15(2):147-148. doi: 10.1183/20734735.0135-2019. PMID: 31191730; PMCID: PMC6544800.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 15 entries